Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue

Molecular Psychiatry

Volumn 2, Issue 2, 1997, Pages 133-136

  Morganti Kossman, M C ^a   Lenzlinger, P M ^a   Hans, V ^a   Stahel, P ^b   Csuka, E ^a   Ammann, E ^a   Stocker, R ^a   Trentz, O ^a   Kossmann, T ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acute phase response; Astrocytes; Blood brain barrier; Brain injury; Interleukins; Nerve growth factor; Transforming growth factor beta; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; BRAIN INJURY; BRAIN TISSUE; CEREBROSPINAL FLUID LEVEL; ENCEPHALITIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030903563     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000227     Document Type: Article

References (18)

1. Morganti-Kossmann MC, Kossmann T. The immunology of brain injury. In: Rothwell N (ed.) Immune Responses in the Nervous System. Bios Scientific Publishers: Oxford, UK, 1995, pp 159-187.
2. Hofman FM, Hinton DR, Johnson K, Merril JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-612.
3. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Naeher-Noe M, Thoenen H. Regulation of nerve growth factor synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1990; 2: 69-76.
4. Gennarelli TA, Spielman GM, Langfit TW, Gildenberg PL, Harrington T, Jane JA, Mashall LF, Miller JF, Pitts LH. Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg 1992; 56: 26-32.
5. Stocker R, Bernays R, Kossmann T, Imhof HG. Monitoring and treatment of acute head injury. In: Goris RJA, Trentz O (eds). The Integrated Approach to Trauma Care. Springer Verlag: Berlin, 1995, pp 197-210.
6. Kossmann T, Hans V, Imhof H-G, Stocker R, Grob P, Trentz O, Morganti-Kossmann MC. Intrathecal and serum interleukin-6 and the acute phase response in patients with severe traumatic brain injuries. Shock 1995; 4: 311-317.
7. Kossmann T, Hans V, Imhof H-G, Trentz O, Morganti-Kossmann MC. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 1996; 713: 143-152.
8. Kossmann T, Stahel P, Lenzlinger P, Redl H, Dubs R, Trentz O, Schlag G, Morganti-Kossmann MC. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood brain barrier dysfunction and nerve growth factor production. J Cerebr Blood F Met (in press).
9. Marmarou A, Abd-Elfattah F, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. J Neurosurg 1994; 80: 291-300.
10. Tibbling G, Link H. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397-401.
11. Benveniste E. The role of cytokines in multiple sclerosis/autoimmune encephalitis and other neurological disorders. In: Agarwal B, Puri R (eds). Human Cytokines, Their Role in Research and Therapy. Blackwell Science: Boston, 1995, pp 195-216.
12. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood brain barrier. Neuroimmunomodulation 1995; 2: 241-248.
13. Young AB, Ott LG, Beard D, Dempsy RJ, Tibbs PA, McClain CJ. The acute-phase response of the brain injured patient. J Neurosurg 1988, 69: 375-380.
14. Lindholm D, Hengerer B, Zafra F, Thoenen H. Transforming growth factor-β1 stimulates the expression of nerve growth factor in the rat CNS. Devel Neurosci 1990; 1: 9-12.
15. Logan A, Oliver JJ, Berry M. Growth factors in CNS repair and regeneration. Prog Growth Factor Res 1995; 5: 379-405.
16. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L. Neurological disease in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 1993; 90: 10061-10065.
17. Morganti-Kossmann MC, Kossmann T, Wahl SM. Cytokines and neuropathology. Trends Pharmacol Sci 1992; 13: 286-291.
18. Rothwell NJ, Relton JK. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 1993; 17: 217-227.